• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

控释吗啡对癌痛患者生活质量的影响。

Effects of controlled-released morphine on quality of life for cancer pain.

作者信息

Ferrell B, Wisdom C, Wenzl C, Brown J

出版信息

Oncol Nurs Forum. 1989 Jul-Aug;16(4):521-6.

PMID:2755859
Abstract

Oncology nursing is concerned with pain relief and overall Quality of Life (QOL). The purpose of this study was to determine the effects of controlled-release morphine on QOL for patients with cancer. Eighty-three subjects were randomly assigned in a clinical trial of short-acting versus controlled-release analgesia (MS Contin, Purdue Frederick Co., Norwalk, CT). Data was collected in a repeated measures design every 2 weeks for 6 weeks yielding a total of 240 visits. Five instruments were used to assess QOL, pain, and functional status. Study findings indicate improved pain management with controlled-release MS Contin and important nursing implications for the management of analgesia-induced gastrointestinal symptoms. Through appropriate pain management with pain therapies such as controlled-release analgesia, nurses can greatly enhance QOL for the patient with cancer.

摘要

肿瘤护理关注疼痛缓解和总体生活质量(QOL)。本研究的目的是确定控释吗啡对癌症患者生活质量的影响。83名受试者被随机分配到一项短效与控释镇痛的临床试验中(美施康定,普渡弗雷德里克公司,诺沃克,康涅狄格州)。采用重复测量设计,每2周收集一次数据,为期6周,共进行240次访视。使用了五种工具来评估生活质量、疼痛和功能状态。研究结果表明,使用控释美施康定可改善疼痛管理,并且对镇痛引起的胃肠道症状的管理具有重要的护理意义。通过使用控释镇痛等疼痛治疗方法进行适当的疼痛管理,护士可以极大地提高癌症患者的生活质量。

相似文献

1
Effects of controlled-released morphine on quality of life for cancer pain.控释吗啡对癌痛患者生活质量的影响。
Oncol Nurs Forum. 1989 Jul-Aug;16(4):521-6.
2
Guidelines for use of controlled-release oral morphine in cancer pain management. Correlation with clinical experience.癌痛管理中口服缓释吗啡的使用指南。与临床经验的相关性。
Cancer Nurs. 1989 Aug;12(4):202-8.
3
A clinical survey of controlled-release morphine sulphate for cancer pain relief in a Japanese hospice.
Postgrad Med J. 1991;67 Suppl 2:S79-81.
4
[Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].[盐酸吗啡缓释片治疗癌痛的效果:567例患者的调查]
Zhonghua Yi Xue Za Zhi. 2004 Mar 17;84(6):450-5.
5
Principles of cancer pain management. Use of long-acting oral morphine.癌症疼痛管理原则。长效口服吗啡的使用。
J Fam Pract. 1989 Mar;28(3):275-80.
6
Morphine: immediate release vs. controlled release.吗啡:即释型与控释型
N C Med J. 1989 Jul;50(7):390-4.
7
Computerized symptom and quality-of-life assessment for patients with cancer part I: development and pilot testing.癌症患者的计算机化症状与生活质量评估 第一部分:开发与初步测试
Oncol Nurs Forum. 2004 Sep 17;31(5):E75-83. doi: 10.1188/04.ONF.E75-E83. Print 2004 Sep.
8
Guidelines for the use of MS Contin tablets in the management of cancer pain.
Postgrad Med J. 1991;67 Suppl 2:S9-12; discussion S13.
9
Symptom distress and quality of life in patients with cancer newly admitted to hospice home care.新入住临终关怀家庭护理的癌症患者的症状困扰与生活质量
Oncol Nurs Forum. 2002 Nov-Dec;29(10):1421-8. doi: 10.1188/02.ONF.1421-1428.
10
The use of sustained-release morphine in a hospice setting.
Pharmatherapeutica. 1987;5(2):99-102.

引用本文的文献

1
Adherence to Analgesics Among Outpatients Seriously Ill With Cancer.癌症晚期门诊患者的镇痛药依从性。
Cancer Nurs. 2022;45(5):337-344. doi: 10.1097/NCC.0000000000001064. Epub 2022 Feb 16.
2
Clinical Practice Guidelines for Pain Management in Acute Musculoskeletal Injury.临床实践指南:急性肌肉骨骼损伤的疼痛管理。
J Orthop Trauma. 2019 May;33(5):e158-e182. doi: 10.1097/BOT.0000000000001430.
3
Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis.
羟考酮与吗啡对中重度癌痛患者镇痛效果的比较:一项荟萃分析。
BMC Anesthesiol. 2018 Sep 24;18(1):132. doi: 10.1186/s12871-018-0583-8.
4
Practical Pharmacology of Methadone: A Long-acting Opioid.美沙酮的实用药理学:一种长效阿片类药物。
Indian J Palliat Care. 2018 Jan;24(Suppl 1):S10-S14. doi: 10.4103/IJPC.IJPC_180_17.
5
Once-Daily OROS Hydromorphone for Management of Cancer Pain: an Open-Label, Multi-Center, Non-Interventional Study.每日一次口服控释羟吗啡酮用于癌症疼痛管理:一项开放标签、多中心、非干预性研究。
J Korean Med Sci. 2016 Dec;31(12):1914-1921. doi: 10.3346/jkms.2016.31.12.1914.
6
Oral morphine for cancer pain.口服吗啡用于癌症疼痛。
Cochrane Database Syst Rev. 2016 Apr 22;4(4):CD003868. doi: 10.1002/14651858.CD003868.pub4.
7
The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain.一种缓释、具有滥用威慑作用的羟考酮/对乙酰氨基酚固定剂量复方产品在急性疼痛治疗中的潜在作用。
Adv Ther. 2015 Jun;32(6):485-95. doi: 10.1007/s12325-015-0213-5. Epub 2015 May 31.
8
Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain.吗啡、芬太尼、羟考酮或可待因用于治疗癌痛时对患者意识、食欲和口渴的影响。
Cochrane Database Syst Rev. 2014 May 29;2014(5):CD011056. doi: 10.1002/14651858.CD011056.pub2.
9
Extended-release morphine sulfate in treatment of severe acute and chronic pain.硫酸吗啡缓释片治疗严重急性和慢性疼痛。
J Pain Res. 2010 Sep 21;3:191-200. doi: 10.2147/JPR.S6529.
10
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain.一项关于每日一次口服控释羟吗啡酮(OROS® hydromorphone)治疗慢性癌痛患者长期安全性和有效性的开放标签、为期1年的扩展研究。
BMC Palliat Care. 2009 Sep 15;8:14. doi: 10.1186/1472-684X-8-14.